Platinum Rechallenge in Patients With Platinum-sensitive mTNBC

NCT02607215 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Vinorelbine
DRUG: DDP

Sponsor

Fudan University